Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Unstable Leukemia Stem Cells may Predispose Patients to Drug Resistance

Published: Wednesday, May 02, 2007
Last Updated: Friday, May 04, 2007
Bookmark and Share
A NIH study shows that BCR-ABL gene in chronic myeloid leukemia stem cells can help explain the reason for resistance of patients to the drug imatinib that target that gene.

The BCR-ABL gene in chronic myeloid leukemia stem cells has a tendency to quickly mutate, and this may help explain why patients are predisposed to resistance to drugs like imatinib that target that gene, according to a study in the May 2 Journal of the National Cancer Institute.

Treatment with imatinib causes clinical remissions in most patients with chronic myeloid leukemia, but relapses are common and the cancer can become resistant to the drug.

The oncogene, BCR-ABL, is the cause of chronic myeloid leukemia. Researchers have hypothesized that the relapses are due to chronic myeloid leukemia stem cells with specific BCR-ABL gene mutations that make them resistant to the drug long before they are exposed to it.

Xiaoyan Jiang, M.D, Ph.D., and Connie Eaves, Ph.D., of the British Columbia Cancer Agency in Vancouver, and colleagues isolated chronic myeloid leukemia stem cells from patients and analyzed them to identify mutations in the BCR-ABL gene.

The stem cells were found to be genetically unstable and had a high frequency of mutations, even in the absence of imatinib. The researchers identified more than 70 BCR-ABL mutations in the stem cells and their immediate progeny, many of which would be expected to alter the BCR-ABL protein - the target of imatinib. This could result in resistance to the drug.

“Although this study was not designed to identify mutations that would contribute to disease progression, our results suggest that these would also be found. These considerations highlight the importance of gaining further understanding of the control of DNA replication and repair in the leukemic stem cells from patients with chronic phase [chronic myeloid leukemia] in future efforts to devise therapies with curative potential,” the authors write.

In an accompanying editorial, Margret Rodrigues, Ph.D., and Martin Sattler, Ph.D., of the Dana Farber Cancer Institute in Boston, discuss the possible causes of genetic instability in the BCR-ABL gene and future approaches to developing successful therapies for chronic myeloid leukemia.

“A future challenge will be to devise approaches that overcome drug resistance within these [chronic myeloid leukemia stem] cells without selecting for additional drug-resistant populations,” the authors write.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Gene Scan Finds Link Across Array of Childhood Brain Disorders
Researchers found gene mutations through whole exome sequencing - a new gene scanning technology that cuts the cost and time of searching for rare mutations.
Friday, August 27, 2010
NIH-Funded Researchers Generate Mature Egg Cells From Early Ovarian Follicles
Technique successful in mice, may offer women new options for fertility treatment.
Monday, August 09, 2010
NIH-Funded Researchers Make Progress Toward Regenerating Tissue to Replace Joints
A team of NIH-funded researchers has successfully regenerated rabbit joints using a cutting edge process to form the joint inside the body, or in vivo.
Monday, August 02, 2010
Gene Associated with Rare Adrenal Disorder Appears to Trigger Cell Death, According to NIH Study
Mice lacking Prkar1a gene in the adrenal glands developed an overgrowth of adrenal tissue and tumors in the gland.
Thursday, July 15, 2010
NIH Opens Website for Human Embryonic Stem Cell Lines for Approval and Announces Members of Working Group
NIH is now accepting requests for human embryonic stem cell lines to be approved for use in NIH-funded research.
Thursday, October 08, 2009
Scientists Report Gene Network in Early Tooth Development
Researchers have deduced a network of dental genes in cichlids that likely was present to build the first tooth some half a billion years ago.
Wednesday, February 11, 2009
NIH Announces Plan to Implement President's Stem Cell Executive Order
The plan calls for aggressively pursuing an assessment of the potential of alternative sources of pluripotent stem cell lines.
Thursday, September 20, 2007
Researchers Isolate Adult Stem Cells for First Time in Tendon
The finding points to a natural source of tendon-producing cells in adults and raises the possibility that these cells one day could help to mend torn or degenerating tendons.
Tuesday, September 11, 2007
Scientific News
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Allen Institute Releases Gene Edited Human Stem Cell Lines
The Allen Cell Collection, a publicly available collection of gene edited pluripotent stem cells, has been made available by the Allen Institute.
Designer Cell Fate Switches Could Streamline Stem Cell Biology
Researchers develop new method of reprogramming cells between cell types in a more efficient way than before.
Improving Drug Production with Computer Model
A model has been developed that can be used to improve and accelerate the production of biotherapeutics, cancer drugs, and vaccines.
Defining the Immortality of Stem Cells
Researchers defined the mechanisms underlying increased protein quality control of pluripotent stem cells.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Enhancing CRISPR to Explore Further
Researchers have developed sOPTiKO, a more efficient and controllable CRISPR genome editing platform.
Stem Cells Police Themselves to Reduce Scarring
Scientists have discovered stem cells in muscle fibers change gene expressions to respond to injury.
Regenerating Diseased Hearts
Researchers from the University of Otago have probed the potential of adult stem cell types to repair diseased hearts.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!